Comparison of Molecular and Histologic Ultrastaging Methods in Sentinel Lymph Node Analysis from Clinical Stage II Colon Cancers.


Journal

Applied immunohistochemistry & molecular morphology : AIMM
ISSN: 1533-4058
Titre abrégé: Appl Immunohistochem Mol Morphol
Pays: United States
ID NLM: 100888796

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 9 8 2019
pubmed: 9 8 2019
medline: 10 5 2020
Statut: ppublish

Résumé

Various studies have demonstrated that occult metastases may be present in patients with clinical stage II colon cancer. The objective of this prospective investigation was to compare the performance of molecular analysis and histologic ultrastaging in detecting occult metastases in sentinel lymph nodes (SLNs). SLNs were collected ex vivo during surgery in 29 patients. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assays were constructed. The results were compared with histologic ultrastaging analysis by hemalum and eosin stain and immunohistochemistry on step serial sections. At least 1 SLN was identified in 76% of the cases. The first hemalum and eosin section identified metastases in 23% of the 22 SLNs. Immunohistochemistry identified isolated tumor cells in 24% of the remaining 17 cases. An overall 73% of the SLNs analyzed by qRT-PCR were positive. Four of them were negative for ultrastaging analysis. qRT-PCR is a powerful tool for the detection of occult metastases in colorectal SLN and seems to be more sensitive than histologic ultrastaging analysis. A larger prospective cohort study is necessary to provide further evidence.

Identifiants

pubmed: 31393285
doi: 10.1097/PAI.0000000000000624
pii: 00129039-201908000-00012
doi:

Substances chimiques

Neoplasm Proteins 0

Types de publication

Clinical Trial Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e65-e70

Auteurs

Olivier Deroo (O)

Departments of Pathology.

David Grand (D)

Department of Pathology, IUCT Oncopole, Toulouse.

Franck Monnien (F)

Departments of Pathology.

Sophie Felix (S)

Departments of Pathology.

Christophe Borg (C)

Oncology, CHRU Besancon, Besançon.
University of Bourgogne Franche-Comté, UBFC, Bourgogne Franche-Comté, France.

Bruno Heyd (B)

Surgery.
University of Bourgogne Franche-Comté, UBFC, Bourgogne Franche-Comté, France.

Stefano Kim (S)

Oncology, CHRU Besancon, Besançon.

Séverine Valmary-Degano (S)

Departments of Pathology.
University of Bourgogne Franche-Comté, UBFC, Bourgogne Franche-Comté, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH